Lectin-like Intestinal Defensin Inhibits 2019-Ncov Spike Binding to ACE2

Cheng Wang,Shaobo Wang,Daixi Li,Xia Zhao,Songling Han,Tao Wang,Gaomei Zhao,Yin Chen,Fang Chen,Jianqi Zhao,Liting Wang,Wei Sun,Yi Huang,Yong-ping Su,Dongqing Wei,Jinghong Zhao,Junping Wang
DOI: https://doi.org/10.1101/2020.03.29.013490
2020-01-01
bioRxiv
Abstract:The burgeoning epidemic caused by novel coronavirus 2019 (2019-nCoV) is currently a global concern. Angiotensin-converting enzyme-2 (ACE2) is a receptor of 2019-nCoV spike 1 protein (S1) and mediates viral entry into host cells. Despite the abundance of ACE2 in small intestine, few digestive symptoms are observed in patients infected by 2019-nCoV. Herein, we investigated the interactions between ACE2 and human defensins (HDs) specifically secreted by intestinal Paneth cells. The lectin-like HD5, rather than HD6, bound ACE2 with a high affinity of 39.3 nM and weakened the subsequent recruitment of 2019-nCoV S1. The cloak of HD5 on the ligand-binding domain of ACE2 was confirmed by molecular dynamic simulation. A remarkable dose-dependent preventive effect of HD5 on 2019-nCoV S1 binding to intestinal epithelial cells was further evidenced by in vitro experiments. Our findings unmasked the innate defense function of lectin-like intestinal defensin against 2019-nCoV, which may provide new insights into the prevention and treatment of 2019-nCoV infection.
What problem does this paper attempt to address?